NUR 600 EXAM 1 NEWEST 2025 ACTUAL EXAM COMPLETE
QUESTIONS AND CORRECT DETAILED ANSWERS (VERIFIED ANSWERS)
|ALREADY GRADED A+|BRAND NEW!!
Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy -
Answer-C. The State Board of Nursing for each state
Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners -
Answer-D. The State Board of Medical Examiners
Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process C.
Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs -
Answer-A. Factoring in the cost to the patient of the medication prescribed
Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for prescribing -
Answer-B. Consulting nationally recognized guidelines for disease management
Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level -
Answer-A. The demonstrated ability of nurse practitioners to control costs and improve
patient outcomes
A patient's nutritional intake and lab work reflects hypoalbuminemia. This is
critical to prescribing because:
A. Distribution of drugs to target tissue may be affected
,B. The solubility of the drug will not match the site of absorption
C. There will be less free drug available to generate an effect
D. Drugs bound to albumin are readily excreted by the kidney -
Answer-A. Distribution of drugs to target tissue may be affected
Drugs that have a significant first-pass effect: A. Must be given by the enteral
(oral) route only
B. Bypass the hepatic circulation
C. Are rapidly metabolized by the liver and may have little if any desired action
D. Are converted by the liver to more active and fat-soluble forms -
Answer-C. Are rapidly metabolized by the liver and may have little if any desired action
The route of excretion of a volatile drug will likely be:
A. The kidneys
B. The lungs
C. The bile and feces
D. The skin -
Answer-B. The lungs
Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage
reservoir of the drug. Storage reservoirs:
A. Assure that the drug will reach its intended target tissue
B. Are the reason for giving loading doses
C. Increase the length of time a drug is available and active
D. Are most common in collagen tissues -
Answer-C. Increase the length of time a drug is available and active
The NP chooses to give cephalexin every 8 hours based on knowledge of the
drug's:
A. Propensity to go to the target receptor
B. Biological half-life
C. Pharmacodynamics
D. Safety and side effects -
Answer-B. Biological half-life
Azithromycin dosing requires the first day's dose be twice those of the other 4
days of the prescription. This is considered a loading dose. A loading dose: A.
Rapidly achieves drug levels in the therapeutic range
B. Requires four to five half-lives to attain
C. Is influenced by renal function
D. Is directly related to the drug circulating to the target tissues -
Answer-A. Rapidly achieves drug levels in the therapeutic range
The point in time on the drug concentration curve that indicates the first sign of a
therapeutic effect is the:
A. Minimum adverse effect level
B. Peak of action
C. Onset of action
D. Therapeutic range -
Answer-C. Onset of action
,Phenytoin requires a trough level be drawn. Peak and trough levels are done: A.
When the drug has a wide therapeutic range
B. When the drug will be administered for a short time only
C. When there is a high correlation between the dose and saturation of receptor sites
D. To determine if a drug is in the therapeutic range -
Answer-D. To determine if a drug is in the therapeutic range
A laboratory result indicates the peak level for a drug is above the minimum toxic
concentration. This means that the:
A. Concentration will produce therapeutic effects
B. Concentration will produce an adverse response
C. Time between doses must be shortened
D. Duration of action of the drug is too long -
Answer-B. Concentration will produce an adverse response
Drugs that are receptor agonists may demonstrate what property?
A. Irreversible binding to the drug receptor site
B. Up-regulation with chronic use
C. Desensitization or down-regulation with continuous use
D. Inverse relationship between drug concentration and drug action -
Answer-C. Desensitization or down-regulation with continuous use
Drugs that are receptor antagonists, such as beta blockers, may cause:
A. Down-regulation of the drug receptor
B. An exaggerated response if abruptly discontinued
C. Partial blockade of the effects of agonist drugs
D. An exaggerated response to competitive drug agonists -
Answer-B. An exaggerated response if abruptly discontinued
Factors that affect gastric drug absorption include:
A. Liver enzyme activity
B. Protein-binding properties of the drug molecule
C. Lipid solubility of the drug
D. Ability to chew and swallow -
Answer-C. Lipid solubility of the drug
Drugs administered via intravenous (IV) route:
A. Need to be lipid soluble in order to be easily absorbed
B. Begin distribution into the body immediately
C. Are easily absorbed if they are nonionized
D. May use pinocytosis to be absorbed -
Answer-B. Begin distribution into the body immediately
When a medication is added to a regimen for a synergistic effect, the combined
effect of the drugs is:
A. The sum of the effects of each drug individually
, B. Greater than the sum of the effects of each drug individually
C. Less than the effect of each drug individually
D. Not predictable, as it varies with each individual -
Answer-B. Greater than the sum of the effects of each drug individually
Which of the following statements about bioavailability is true?
A. Bioavailability issues are especially important for drugs with narrow therapeutic
ranges or sustained release mechanisms.
B. All brands of a drug have the same bioavailability.
C. Drugs that are administered more than once a day have greater bioavailability than
drugs given once daily.
D. Combining an active drug with an inert substance does not affect -
Answer-A. Bioavailability issues are especially important for drugs with narrow
therapeutic ranges or sustained release mechanisms.
Which of the following statements about the major distribution barriers (blood
brain or fetal-placental) is true?
A. Water soluble and ionized drugs cross these barriers rapidly.
B. The blood-brain barrier slows the entry of many drugs into and from brain cells.
C. The fetal-placental barrier protects the fetus from drugs taken by the mother.
D. Lipid soluble drugs do not pass these barriers and are safe for pregnant women -
Answer-B. The blood-brain barrier slows the entry of many drugs into and from brain
cells.
Drugs are metabolized mainly by the liver via Phase I or Phase II reactions. The
purpose of both of these types of reactions is to:
A. Inactivate prodrugs before they can be activated by target tissues
B. Change the drugs so they can cross plasma membranes
C. Change drug molecules to a form that an excretory organ can excrete
D. Make these drugs more ionized and polar to facilitate excretion -
Answer-C. Change drug molecules to a form that an excretory organ can excrete
Once they have been metabolized by the liver, the metabolites may be:
A. More active than the parent drug
B. Less active than the parent drug
C. Totally "deactivated" so that they are excreted without any effect
D. All of the above -
Answer-D. All of the above
All drugs continue to act in the body until they are changed or excreted. The
ability of the body to excrete drugs via the renal system would be increased
by:
A. Reduced circulation and perfusion of the kidney
B. Chronic renal disease
C. Competition for a transport site by another drug
D. Unbinding a nonvolatile drug from plasma proteins -
Answer-D. Unbinding a nonvolatile drug from plasma proteins
QUESTIONS AND CORRECT DETAILED ANSWERS (VERIFIED ANSWERS)
|ALREADY GRADED A+|BRAND NEW!!
Nurse practitioner prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing for each state
D. The State Board of Pharmacy -
Answer-C. The State Board of Nursing for each state
Physician Assistant (PA) prescriptive authority is regulated by:
A. The National Council of State Boards of Nursing
B. The U.S. Drug Enforcement Administration
C. The State Board of Nursing
D. The State Board of Medical Examiners -
Answer-D. The State Board of Medical Examiners
Clinical judgment in prescribing includes:
A. Factoring in the cost to the patient of the medication prescribed
B. Always prescribing the newest medication available for the disease process C.
Handing out drug samples to poor patients
D. Prescribing all generic medications to cut costs -
Answer-A. Factoring in the cost to the patient of the medication prescribed
Criteria for choosing an effective drug for a disorder include:
A. Asking the patient what drug they think would work best for them
B. Consulting nationally recognized guidelines for disease management
C. Prescribing medications that are available as samples before writing a prescription
D. Following U.S. Drug Enforcement Administration (DEA) guidelines for prescribing -
Answer-B. Consulting nationally recognized guidelines for disease management
Nurse practitioner practice may thrive under health-care reform due to:
A. The demonstrated ability of nurse practitioners to control costs and improve patient
outcomes
B. The fact that nurse practitioners will be able to practice independently
C. The fact that nurse practitioners will have full reimbursement under health-care
reform
D. The ability to shift accountability for Medicaid to the state level -
Answer-A. The demonstrated ability of nurse practitioners to control costs and improve
patient outcomes
A patient's nutritional intake and lab work reflects hypoalbuminemia. This is
critical to prescribing because:
A. Distribution of drugs to target tissue may be affected
,B. The solubility of the drug will not match the site of absorption
C. There will be less free drug available to generate an effect
D. Drugs bound to albumin are readily excreted by the kidney -
Answer-A. Distribution of drugs to target tissue may be affected
Drugs that have a significant first-pass effect: A. Must be given by the enteral
(oral) route only
B. Bypass the hepatic circulation
C. Are rapidly metabolized by the liver and may have little if any desired action
D. Are converted by the liver to more active and fat-soluble forms -
Answer-C. Are rapidly metabolized by the liver and may have little if any desired action
The route of excretion of a volatile drug will likely be:
A. The kidneys
B. The lungs
C. The bile and feces
D. The skin -
Answer-B. The lungs
Medroxyprogesterone (Depo Provera) is prescribed IM to create a storage
reservoir of the drug. Storage reservoirs:
A. Assure that the drug will reach its intended target tissue
B. Are the reason for giving loading doses
C. Increase the length of time a drug is available and active
D. Are most common in collagen tissues -
Answer-C. Increase the length of time a drug is available and active
The NP chooses to give cephalexin every 8 hours based on knowledge of the
drug's:
A. Propensity to go to the target receptor
B. Biological half-life
C. Pharmacodynamics
D. Safety and side effects -
Answer-B. Biological half-life
Azithromycin dosing requires the first day's dose be twice those of the other 4
days of the prescription. This is considered a loading dose. A loading dose: A.
Rapidly achieves drug levels in the therapeutic range
B. Requires four to five half-lives to attain
C. Is influenced by renal function
D. Is directly related to the drug circulating to the target tissues -
Answer-A. Rapidly achieves drug levels in the therapeutic range
The point in time on the drug concentration curve that indicates the first sign of a
therapeutic effect is the:
A. Minimum adverse effect level
B. Peak of action
C. Onset of action
D. Therapeutic range -
Answer-C. Onset of action
,Phenytoin requires a trough level be drawn. Peak and trough levels are done: A.
When the drug has a wide therapeutic range
B. When the drug will be administered for a short time only
C. When there is a high correlation between the dose and saturation of receptor sites
D. To determine if a drug is in the therapeutic range -
Answer-D. To determine if a drug is in the therapeutic range
A laboratory result indicates the peak level for a drug is above the minimum toxic
concentration. This means that the:
A. Concentration will produce therapeutic effects
B. Concentration will produce an adverse response
C. Time between doses must be shortened
D. Duration of action of the drug is too long -
Answer-B. Concentration will produce an adverse response
Drugs that are receptor agonists may demonstrate what property?
A. Irreversible binding to the drug receptor site
B. Up-regulation with chronic use
C. Desensitization or down-regulation with continuous use
D. Inverse relationship between drug concentration and drug action -
Answer-C. Desensitization or down-regulation with continuous use
Drugs that are receptor antagonists, such as beta blockers, may cause:
A. Down-regulation of the drug receptor
B. An exaggerated response if abruptly discontinued
C. Partial blockade of the effects of agonist drugs
D. An exaggerated response to competitive drug agonists -
Answer-B. An exaggerated response if abruptly discontinued
Factors that affect gastric drug absorption include:
A. Liver enzyme activity
B. Protein-binding properties of the drug molecule
C. Lipid solubility of the drug
D. Ability to chew and swallow -
Answer-C. Lipid solubility of the drug
Drugs administered via intravenous (IV) route:
A. Need to be lipid soluble in order to be easily absorbed
B. Begin distribution into the body immediately
C. Are easily absorbed if they are nonionized
D. May use pinocytosis to be absorbed -
Answer-B. Begin distribution into the body immediately
When a medication is added to a regimen for a synergistic effect, the combined
effect of the drugs is:
A. The sum of the effects of each drug individually
, B. Greater than the sum of the effects of each drug individually
C. Less than the effect of each drug individually
D. Not predictable, as it varies with each individual -
Answer-B. Greater than the sum of the effects of each drug individually
Which of the following statements about bioavailability is true?
A. Bioavailability issues are especially important for drugs with narrow therapeutic
ranges or sustained release mechanisms.
B. All brands of a drug have the same bioavailability.
C. Drugs that are administered more than once a day have greater bioavailability than
drugs given once daily.
D. Combining an active drug with an inert substance does not affect -
Answer-A. Bioavailability issues are especially important for drugs with narrow
therapeutic ranges or sustained release mechanisms.
Which of the following statements about the major distribution barriers (blood
brain or fetal-placental) is true?
A. Water soluble and ionized drugs cross these barriers rapidly.
B. The blood-brain barrier slows the entry of many drugs into and from brain cells.
C. The fetal-placental barrier protects the fetus from drugs taken by the mother.
D. Lipid soluble drugs do not pass these barriers and are safe for pregnant women -
Answer-B. The blood-brain barrier slows the entry of many drugs into and from brain
cells.
Drugs are metabolized mainly by the liver via Phase I or Phase II reactions. The
purpose of both of these types of reactions is to:
A. Inactivate prodrugs before they can be activated by target tissues
B. Change the drugs so they can cross plasma membranes
C. Change drug molecules to a form that an excretory organ can excrete
D. Make these drugs more ionized and polar to facilitate excretion -
Answer-C. Change drug molecules to a form that an excretory organ can excrete
Once they have been metabolized by the liver, the metabolites may be:
A. More active than the parent drug
B. Less active than the parent drug
C. Totally "deactivated" so that they are excreted without any effect
D. All of the above -
Answer-D. All of the above
All drugs continue to act in the body until they are changed or excreted. The
ability of the body to excrete drugs via the renal system would be increased
by:
A. Reduced circulation and perfusion of the kidney
B. Chronic renal disease
C. Competition for a transport site by another drug
D. Unbinding a nonvolatile drug from plasma proteins -
Answer-D. Unbinding a nonvolatile drug from plasma proteins
